Researcher profile · Semantic Scholar

Hui Sun

h-index: 14
Works: 28
Citations: 587

Most-cited papers

A narrative review of tumor heterogeneity and challenges to tumor drug therapy
Liang Zhu, Min-Lin Jiang, Hao Wang, Hui Sun +8 more
2021Annals of Translational Medicine141 citations Open access
Semantic Scholar
Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis
Xiaoying Wan, Bo-xiong Xie, Hui Sun, Wei-qing Gu +3 more
2022Cancer Cell International53 citations Open access
Semantic Scholar
Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules.
Yi-Nan Liu, Hui Sun, Fei Zhou, C. Su +5 more
2017Lung Cancer49 citations
Semantic Scholar
EBUS-TBNA Provides Highest RNA Yield for Multiple Biomarker Testing from Routinely Obtained Small Biopsies in Non-Small Cell Lung Cancer Patients - A Comparative Study of Three Different Minimal Invasive Sampling Methods
G. Schmid-Bindert, Yong-Sheng Wang, Hong-Bin Jiang, Hui Sun +5 more
2013PLoS ONE48 citations Open access
Semantic Scholar
Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer
Qin-Fang Deng, Qiyu Fang, Bo-xiong Xie, Hui Sun +2 more
2020Aging37 citations Open access
Semantic Scholar
Microbes in lung cancer initiation, treatment, and outcome: boon or bane?
Haoyue Guo, Lishu Zhao, Jun-Jie Zhu, Peixin Chen +12 more
2021Seminars in Cancer Biology35 citations
Semantic Scholar
Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients
Xiaoxia Chen, Hui Sun, S. Ren, Vikramsingh Kim Curran +4 more
2012Clinical and Translational Oncology27 citations
Semantic Scholar
FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III
Min-Lin Jiang, Chun-Yan Wu, Li-Ping Zhang, Chenglong Sun +12 more
2021Journal for ImmunoTherapy of Cancer26 citations Open access
Semantic Scholar
Continuation of gefitinib plus chemotherapy prolongs progression-free survival in advanced non-small cell lung cancer patients who get acquired resistance to gefitinib without T790M mutations.
T. Ding, Fei Zhou, Xiaoxia Chen, Shi-Jia Zhang +7 more
2017Journal of Thoracic Disease26 citations Open access
Semantic Scholar
Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC.
Shuo Yang, S. Mao, Xue-Fei Li, Chao Zhao +17 more
2019Lung Cancer23 citations
Semantic Scholar
Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
Ya-Yi He, Lele Song, Hao Wang, Peixin Chen +18 more
2020Advancement of science17 citations Open access
Semantic Scholar
Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma.
Ya-Yi He, Xiao-Gang Liu, Hao Wang, Liang Wu +9 more
2021Small Methods16 citations
Semantic Scholar
Lymphocyte activation gene-3 is associated with programmed death-ligand 1 and programmed cell death protein 1 in small cell lung cancer
Hui Sun, Jia-qi Dai, Lishu Zhao, Jun Zhu +5 more
2021Annals of Translational Medicine15 citations Open access
Semantic Scholar
Comparison between the first-line and second-line immunotherapy drugs in the progression-free survival and overall survival in advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials.
Shengyu Wu, Lei Wang, Wei Li, Bin Chen +6 more
2020Annals of Palliative Medicine14 citations Open access
Semantic Scholar
Bibliometric Insights in Advances of Anaplastic Thyroid Cancer: Research Landscapes, Turning Points, and Global Trends
Han-Yu Wang, Yuxin Yu, Kang Wang, Hui Sun
2021Frontiers in Oncology12 citations Open access
Semantic Scholar
Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis
Qin-Fang Deng, Qiyu Fang, Hui Sun, Aditi P. Singh +4 more
2020Cancer Medicine12 citations Open access
Semantic Scholar
Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer
Qiyu Fang, Xiaoying Wan, A. D'Aiello, Hui Sun +7 more
2023Frontiers in Oncology8 citations Open access
Semantic Scholar
Risk-score model to predict prognosis of malignant airway obstruction after interventional bronchoscopy
Min-Lin Jiang, Hao-Jie Xu, Dongmei Yu, Li Yang +15 more
2021Translational Lung Cancer Research8 citations Open access
Semantic Scholar
Netrin-1 promotes retinoblastoma-associated angiogenesis
Xiaosheng Yang, Hui Sun, Tianchi Tang, Wen-Chuan Zhang +1 more
2021Annals of Translational Medicine7 citations Open access
Semantic Scholar
Cryoablation Activates the cGAS–STING‐CXCL10 Axis in Macrophages to Enhance Anti‐Tumor Immunity in NSCLC
Xin-Xin Zhi, Zhengcao Xing, Libo Luo, Jia-Le Wang +14 more
2026Advancement of science5 citations Open access
Semantic Scholar
Hypoproteinemia being a manifestation of immunotherapy-related liver dysfunction.
Juan Deng, Xiaoxia Chen, Hui Sun, Yu Liu +10 more
2020Annals of Translational Medicine5 citations Open access
Semantic Scholar
ID1对非小细胞肺癌EGFR-TKI耐药的影响
Yu-Chen Bao, Yinmin Zhao, Bin Chen, Jie Luo +4 more
2016Zhongguo fei ai za zhi = Chinese journal of lung cancer4 citations
Semantic Scholar
Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor Heterogeneity
Haoyue Guo, Bin Chen, Wei Li, Hao Wang +8 more
2021Journal of Healthcare Engineering3 citations Open access
Semantic Scholar
Association of XRCC3 and XPD751 SNP with response to platinum-based chemotherapy in advanced NSCLC patients.
Xiaoxia Chen, Cheng-Zhi Zhou, Hui Sun, S. Ren +2 more
2011Journal of Clinical Oncology1 citations
Semantic Scholar
Ablation plus immunotherapy in advanced NSCLC patients who develop oligo-residual disease after anti–PD-1/L1 therapy: Updated results from the BOOSTER trial.
Shuo Yang, Xin-Yu Liu, Jia Yu, Xiao-Zhen Liu +12 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Circulating free DNA (cfDNA) for personalized treatment of lung cancer patients without cytopathologic diagnosis.
Aditi P. Singh, Qin-Fang Deng, Qiyu Fang, Hui Sun +3 more
20180 citations
Semantic Scholar
The efficacy of chemotherapy in the advanced NSCLC patients who failed with the treatment of EGFR-TKI.
S. Zhou, S. Ren, Li-Ping Zhang, Hui Sun +1 more
2009Journal of Clinical Oncology0 citations
Semantic Scholar
The efficacy and safety of loading dose ibandronate in the treatment of non-small cell lung cancer metastatic bone pain(MBP)
S. Ren, Lan-Jun Zhang, C. Zhou, S. Zhou +1 more
20080 citations
Semantic Scholar

Min-Lin Jiang

×7

Qiyu Fang×7

Peixin Chen×7

Bin Chen×7

Xiaoxia Chen×7

Qin-Fang Deng×6

Song-Wen Zhou×6

Shengyu Wu×5